- ticket title
- LONGi unveils RE100 roadmap to achieve 100% green energy use by 2028
- THRIVE II: This Is What It Takes releases trailer August 8th in 15 languages for sequel to one of the top watched documentaries of all time
- First liquid biopsy to receive FDA Approval for comprehensive tumor profiling across all solid cancers, Guardant Health’s Guardant360® CDx, gains credibility among oncologists in Asia, Middle East and Africa.
- Miami International Holdings Reports July 2020 Trading Results for MIAX Exchange Group; July Market Share up Approximately 19% over 2019
- التقنيات المعززة تساعد منصات التجارة الإلكترونية والتجار على تقديم تجربة بث حي أكثر ذكاء على الإنترنت
May 1, 2019
Powered by Philips’ HealthSuite digital platform, new General Practitioner telehealth service from Chipmunk Health aims to forge a closer and more effective relationship between patients and their doctors while improving health outcomes
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that telehealth service provider Chipmunk Health, with locations in the Netherlands and Canada, is leveraging the capabilities and services of Philips’ HealthSuite digital platform to roll out its new GP-to-patient home monitoring solutions.
Designed to allow general practitioners to keep a closer check on the health status of their patients, Chipmunk Health’s telehealth services offer patients a closer relationship with their GP, without the waiting time and inconvenience of having to visit their GP for routine check-ups. The company will use the open, cloud-based infrastructure and services of Philips’ HealthSuite digital platform to connect multiple home monitoring devices, aggregate the acquired data via a dedicated smart hub, and securely transmit, store and analyze it.
“Philips’ HealthSuite digital platform is a vitally important element in rolling out our new services and scaling them up in a safe and secure way,” said Erik Duijsens, founder and CEO of Chipmunk Health. “We are convinced that our consumer-oriented telehealth services will provide more effective and qualitatively better healthcare than we already have, and at lower cost. Patients will be able to access all their health data in one place and doctors will be better equipped to serve their patients’ complex needs.”
“Many Innovative telehealth start-ups have excellent ideas but don’t have the resources to develop the secure, privacy-protected data infrastructure needed to unify and connect devices and data, and securely transmit, store and analyze patient data,” said Dale Wiggins, Philips’ Business Leader for the HealthSuite digital platform. “Supporting innovative companies like Chipmunk Health is one of the reasons why we made HealthSuite an open digital platform on which third parties can build their own applications. We are delighted that Chipmunk has joined the growing number of companies that recognize the growth and scale-up potential of our platform.”
Today’s announcement follows similar recent agreements to use Philips’ HealthSuite digital platform by eye care provider Alcon, selfcare solutions company Ypsomed, and Internet of Things (IoT) managed service provider Integron. In such collaborations, Philips is the provider of the relevant cloud-based healthcare IT infrastructure and not involved in the commercialization of the products and services of these companies.
Philips HealthSuite digital platform
Philips’ HealthSuite digital platform offers companies Cloud-based services and technical tools that meet privacy, security and regulatory requirements that they can use to develop and run a new generation of connected healthcare applications. Unlike other digital platforms, HealthSuite is purpose-built to solve the complex challenges of healthcare, featuring capabilities to connect devices, collect personal and health data, store and share data securely, analyze data, build and deploy AI models, and create solutions on the Cloud.
For further information, please contact:
Philips Group Press Office
Tel: +31 6 10 55 8116
Philips Group Press Office
Tel: +31 6 1521 3446
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.